BioLux
INNOVATION
SCIENTIFIC RESEARCH
RESPONSIBILITY
HEALTH
CUSTOMER SATISFACTION
Since the creation of Biolux technology in 2007, our ambition has been to make non-invasive and effective medical treatments accessible at home. Not to replace healthcare professionals, but rather to support them and allow them to remotely monitor and track the progress of treatments, from the doctor's office to the patient's home.
Empowering patients to make their own decisions about their treatments while respecting health and medical constraints has been a constant challenge. Scientific and technological expertise, along with control over its regulated therapeutic application, has been essential to Laboratoire ISC's approach in promoting Biolux technology to the widest possible audience.
Circumstantial events, such as COVID-19 and the need to find remote treatment solutions, have catalyzed this positioning and reinforced our strategic choices.
The context, the environment, and the various clinical evaluation criteria can only be taken into account remotely if the technology becomes connected and intelligent. (M-IOT/Mtech)
BioPhotomodulation, which is a branch of light therapy, using the cold light of light-emitting diodes for medical purposes, is very effective in treating neuro dermatological and dermato-aesthetic problems, but it was necessary to understand its functioning at the scientific level and its mechanisms of action at the cellular level.
Investments in R&D and clinical trials since the beginning have allowed the laboratory to demonstrate the effectiveness of its treatments on significant pathologies for which there were previously no real solutions.
Intelligent treatment devices have been developed and registered as medical devices worldwide, taking into account ethnic and cultural diversity. The reproducibility and effectiveness of Biolux treatments have allowed us to be recognized as experts in light therapy.
Investing in research and clinical trials from the outset to prove the medical efficacy of a technology enables us today to offer a wide range of treatment protocols in the fields of dermatological aesthetics and wellness, which are easy to apply, cost-effective, and free of side effects.
Reducing the cost of aesthetic and medical treatments, providing more specific and personalized topical care, while ensuring information and follow-up for both patients and professionals, have been the core values of the ISC laboratory since its inception.
The second generation of LUXe is a concentrate of technology, it offers robust and efficient protocols, thanks to the 5 families of integrated LEDs. Home treatments are controlled and 100% reproducible. The LUXe is currently the only smart device to benefit from international clinical and technical recognition.
Research and science are at the heart of our values.
All our devices are CE Medical, FDA and CMDCAS certified.
THE BIOLUX STORY:
TEN YEARS OF RESEARCH
-
2007
Launch of research in exclusive partnership with the Institute of Neurosciences of Montpellier. Filing of technological patents.
-
2009Creation of Biolux Medical in France
-
2010
International launch of the first Home Care LUXe Anti-Age photomodulation device.
-
2011
Launch of the Ecocert-certified Light+ cosmetic range
-
2012
Launch of the first Home care device Luxe Blue for the treatment of acne, certified Medical Class IIa & Creation of the aesthetic subsidiary in France Biolux Institute
-
2013
Launch of the professional device LUXe Pro and the interactive platform LUXe Manager
-
2014Launch of the professional device
-
2015Acquisition of Biolux Medical by Intelligent Sensory Concept ( ISC ). Creation of a multidisciplinary team in Geneva for the development of new treatment protocols in partnership with Swiss clinics.
-
2016Publication of the multicenter study France, Switzerland, Brazil on our 4 axes of research: regeneration, inflammation, healing & pain
-
2017Creation of ISC medical France & USA. Registration of the Aesthetic and medical range in Brazil
-
2018Launch of the new Home care range and of the Physiotherapy segment
-
2021Launch of the new Home care LUXe 2.0, the first connected device for medico-aesthetic applications.
-
2022Launch of LUXe Platinium Home care integrating aesthetic, medical and physiotherapy treatments